SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001615774-16-004346
Filing Date
2016-02-29
Accepted
2016-02-29 17:16:37
Documents
45
Period of Report
2015-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K s102646_10k.htm 10-K 522026
2 EXHIBIT 31-1 s102646_ex31-1.htm EX-31.1 8503
3 EXHIBIT 31-2 s102646_ex31-2.htm EX-31.2 8463
4 EXHIBIT 32 s102646_ex32.htm EX-32 4663
  Complete submission text file 0001615774-16-004346.txt   2219529

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cnlm-20151130.xml EX-101.INS 243628
6 XBRL SCHEMA FILE cnlm-20151130.xsd EX-101.SCH 28460
7 XBRL CALCULATION FILE cnlm-20151130_cal.xml EX-101.CAL 32729
8 XBRL DEFINITION FILE cnlm-20151130_def.xml EX-101.DEF 81934
9 XBRL LABEL FILE cnlm-20151130_lab.xml EX-101.LAB 197413
10 XBRL PRESENTATION FILE cnlm-20151130_pre.xml EX-101.PRE 153917
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK SUITE 105 BURLINGTON MA 01803 781-652-4500
CB Pharma Acquisition Corp. (Filer) CIK: 0001619551 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 001-36757 | Film No.: 161469553
SIC: 6770 Blank Checks